Free Trial

National Vision (EYE) Competitors

National Vision logo
$22.94 -0.46 (-1.97%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$22.94 0.00 (0.00%)
As of 08/29/2025 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EYE vs. NVST, STVN, IRTC, GKOS, BLCO, TMDX, SLNO, LIVN, WRBY, and INSP

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

National Vision vs. Its Competitors

Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

In the previous week, National Vision had 1 more articles in the media than Envista. MarketBeat recorded 8 mentions for National Vision and 7 mentions for Envista. National Vision's average media sentiment score of 1.35 beat Envista's score of 1.27 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista has a net margin of 2.11% compared to National Vision's net margin of -0.75%. Envista's return on equity of 4.84% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.11% 4.84% 2.68%
National Vision -0.75%3.56%1.49%

Envista presently has a consensus target price of $20.92, indicating a potential downside of 1.05%. National Vision has a consensus target price of $24.73, indicating a potential upside of 7.79%. Given National Vision's stronger consensus rating and higher possible upside, analysts plainly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33
National Vision
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

National Vision has lower revenue, but higher earnings than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.51B1.40-$1.12B$0.3266.08
National Vision$1.89B0.96-$28.50M-$0.18-127.44

Envista has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, National Vision has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Summary

Envista beats National Vision on 8 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$1.82B$33.49B$16.29B$9.76B
Dividend YieldN/A2.59%3.03%4.04%
P/E Ratio-127.4439.9118.5926.59
Price / Sales0.961.9248.60111.49
Price / Cash14.0216.3714.8159.26
Price / Book2.147.295.836.58
Net Income-$28.50M$1.23B$682.79M$265.95M
7 Day Performance-7.61%-1.00%-0.82%0.17%
1 Month Performance-5.44%8.11%1.27%3.90%
1 Year Performance117.23%17.87%3.89%19.67%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.8665 of 5 stars
$22.94
-2.0%
$24.73
+7.8%
+117.2%$1.82B$1.89B-127.4413,411Positive News
Insider Trade
NVST
Envista
4.0666 of 5 stars
$21.15
-2.6%
$20.92
-1.1%
+15.8%$3.61B$2.51B66.1012,300News Coverage
Positive News
Analyst Downgrade
STVN
Stevanato Group
3.0247 of 5 stars
€21.99
-2.8%
N/A+5.8%€6.66B€1.19B40.725,521News Coverage
Positive News
IRTC
iRhythm Technologies
1.4201 of 5 stars
$165.68
-2.0%
$162.64
-1.8%
+139.8%$5.43B$591.84M-56.552,000News Coverage
Positive News
Analyst Forecast
GKOS
Glaukos
4.6845 of 5 stars
$91.78
-2.5%
$127.42
+38.8%
-28.4%$5.40B$383.48M-55.62780News Coverage
Positive News
BLCO
Bausch + Lomb
1.7917 of 5 stars
$14.57
-2.5%
$15.56
+6.8%
-10.9%$5.29B$4.79B-18.6713,500
TMDX
TransMedics Group
3.2778 of 5 stars
$114.97
-4.1%
$123.00
+7.0%
-31.6%$4.09B$441.54M59.57210News Coverage
Positive News
Analyst Downgrade
SLNO
Soleno Therapeutics
4.5066 of 5 stars
$66.51
-3.0%
$115.09
+73.0%
+38.2%$3.64BN/A-16.0730News Coverage
Analyst Forecast
LIVN
LivaNova
1.5494 of 5 stars
$56.35
+0.8%
$59.71
+6.0%
+11.9%$3.05B$1.25B-14.492,900Positive News
WRBY
Warby Parker
2.083 of 5 stars
$26.18
-3.1%
$24.06
-8.1%
+75.4%$2.84B$771.32M-373.883,780News Coverage
Analyst Upgrade
INSP
Inspire Medical Systems
4.9819 of 5 stars
$93.20
-2.9%
$165.62
+77.7%
-47.7%$2.84B$802.80M53.881,246Positive News

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners